ghk-cu and zinc 50mg Copper Peptide Research-Grade Fountain Health NYC – GHK-Cu

Injectable GHK-Cu was in Category 2 the more restrictive category for substances with "significant safety concerns." Its removal from Category 2 is the more positive development, as it signals the FDA no longer considers injectable GHK-Cu to carry the safety risk level that warranted Category 2 placement

It is investigated in experimental models for its interaction with growth factor signaling, angiogenesis-related mechanisms, and cytoprotective process

The peptide has not undergone the extensive clinical testing typically required for regulatory approval as a pharmaceutical treatment in the United States or European Union

More receptors with no GH to fill them are just doors that lead nowhere